As of 2019, it is listed by the World Health Organization (WHO) as the first-line treatment for adults with HIV/AIDS, with<unk> /lamivudine/efavirenz as an alternative. It may be used in people with both HIV and tuberculosis, however if the person is on rifampicin a larger dose of<unk>  is needed.
Dolutegravir/lamivudine/tenofovir
Lamivudine/tenofovir
Abacavir/lamivudine
Doravirine/lamivudine/tenofovir
Atazanavir/ritonavir
Abacavir/lamivudine/zidovudine
Lamivudine/nevirapine/zidovudine
Lamivudine/zidovudine